Healthcare Industry News: proton
News Release - January 24, 2008
Varian and BrainLAB Announce Rapid Uptake of Powerful and Versatile Radiosurgery PlatformFourteen Novalis Tx(TM) Orders Since September Launch Reinforce Strength of Partnership
PALO ALTO, Calif. and MUNICH, Germany, Jan. 24 (HSMN NewsFeed) -- Varian Medical Systems (NYSE: VAR ) and BrainLAB AG are today announcing that they have booked fourteen orders for the new Novalis Tx(TM) radiosurgical platform, which combines the most successful technologies from both companies to offer superior noninvasive treatment options for patients. The orders for the Novalis Tx platform, which was launched in September 2007, include 10 in the United States and four in Europe.
"Novalis Tx orders have come in at twice the rate normally seen for any type of radiosurgical device and we are delighted with the early response from the surgical community," says Dow Wilson, President of Varian's Oncology Systems business. "We have received orders from some of the world's leading surgical and radiotherapy centers as well as from community hospitals that are intent on enhancing their radiosurgical capabilities."
Jean Hooks, General Manager Oncology Solutions at BrainLAB, adds, "The imaging capabilities Novalis Tx offers are unmatched in the industry and are representative of the power our partnership brings to the field of radiosurgery. Novalis Tx answers strong demand from the clinical community for a fast, versatile, ultra-precise radiosurgery device that advances current standards of care."
Novalis Tx offers a wide range of treatment options for a large number of indications, including malignant and benign lesions, brain metastases, arteriovascular malformations, and functional lesions. It features the highest dose delivery rates in the industry, dynamic ultra-fine beam shaping, and frameless patient positioning for more rapid, effective, and comfortable treatments.
"Novalis Tx has the dose delivery rate, advanced imaging, and high definition beam shaping capability needed to offer faster, more precise, more comfortable radiosurgical procedures for our patients," said Fang-Fang Yin, Ph. D., professor and director of radiation physics at Duke University School of Medicine, which is completing the installation of a Novalis Tx.
Unlike other radiosurgical devices, Novalis Tx allows multiple beam energies from 6 to 20 million electron volts for treating deep-seated tumors and sparing surrounding healthy tissue more effectively. Clinics can treat twice the number of patients per day than with any other stereotactic radiosurgery system on the market. "The speed coupled with the precise beam shaping and advanced imaging capabilities make the most advanced radiosurgical treatments more affordable for hospitals and their patients," adds Dow Wilson.
About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing
comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 4,400 people who are located at manufacturing sites in North America and Europe and in its 60 sales and support offices around the world. For more information, visit http://www.varian.com/.
BrainLAB develops, manufactures and markets software-driven medical technology that enables procedures that are more precise, less invasive, and also less expensive than traditional treatments. Among the core products are image-guided systems that provide highly accurate real-time information used for navigation during surgical procedures. This utility has been further expanded to serve as a computer terminal for physicians to more effectively access and interpret diagnostic scans and other digital medical information for better informed decisions. BrainLAB solutions allow expansion from a single system to operating suites to digitally integrated hospitals covering all subspecialties from neurosurgery, orthopedics, ENT, CMF to spine & trauma and oncology. With more than 2,950 systems installed in over 70 countries, BrainLAB is a market leader in image-guided technology. The privately held BrainLAB group, founded in 1989, is headquartered in Munich, Germany and today employs more than 950 people in 16 offices across Europe, Asia, Australia, North and South America.
For more information, visit BrainLAB at http://www.brainlab.com.
Source: Varian Medical Systems
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsThree Radiotherapy Centers in Serbia Standardize on Varian Solution for Cancer Treatment Planning
Varian to Expand Interventional Oncology Portfolio with Purchase of Embolic Bead Asset
Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at New Treatment Center in Singapore